Matching articles for "Optune Pax"
Issue 1752 · April 13, 2026 Free
In Brief: Optune Pax — A Portable Device for Pancreatic Cancer (online only)

Optune Pax (Novocure), a portable device that delivers low-intensity alternating electrical fields to the abdomen, has been approved by the FDA for use with gemcitabine and nab-paclitaxel (GnP) for treatment…

Med Lett Drugs Ther. 2026 Apr 13; 68(1752):e64 doi:10.58347/tml.2026.1752g
Optune Pax (Novocure), a portable device that delivers low-intensity alternating electrical fields to the abdomen, has been approved by the FDA for use with gemcitabine and nab-paclitaxel (GnP) for treatment of locally advanced pancreatic cancer in adults. It is the first device to be approved in the US for treatment of pancreatic cancer. Similar devices are available for treatment of certain lung cancers (Optune Lua) and glioblastoma (Optune Gio) .